HTR1A and psychiatric disorder: We therefore propose that (sub)chronic treatment with selective and highly efficacious ‘autoreceptor biased’ 5-HT1A agonists like F13714 may have clinical potency to normalize (trait-like) excessive aggressive and violent conduct in patients with different psychiatric disorders or neurodegenerative diseases like Alzheimer’s.